For the patient. New treatments for heart failure in Black people. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
Ajayi
Adesuyi A Leslie
AA
Sofowora
Gbenga G
GG
Adigun
Adegboyega Q
AQ
Asiyanbola
Bola
B
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D044383:Black People; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000627:therapeutic use; D017079:Exercise Tolerance / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy* / Q000208:ethnology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000208:ethnology; D009549:Nigeria / Q000453:epidemiology; D011224:Prazosin / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001262:Atenolol; D004656:Enalapril; D011224:Prazosin